Semantic search
From FANTOM5_SSTAR
Mouse (Mus musculus)
- 10689-109F5 (mixed mullerian tumor cell line:HTMMT)
- 10690-109F6
- 10691-109F7 (meningioma cell line:HKBMM)
- 10692-109F8 (large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF)
- 10693-109F9 (serous cystadenocarcinoma cell line:HTOA)
- 10694-109G1 (tridermal teratoma cell line:HGRT)
- 10695-109G2 (sacrococcigeal teratoma cell line:HTST)
- 10697-109G4 (peripheral neuroectodermal tumor cell line:KU-SN)
- 10698-109G5 (pancreatic carcinoma cell line:NOR-P1)
- 10699-109G6 (acute myeloid leukemia (FAB M7) cell line:M-MOK)
- 10700-109G7 (chondrosarcoma cell line:SW 1353)
- 10701-109G8
- 10702-109G9 (basal cell carcinoma cell line:TE 354.T)
- 10703-109H1 (carcinoid cell line:NCI-H1770)
- 10704-109H2 (osteoclastoma cell line:Hs 706.T)
- 10705-109H3 (Ewing's sarcoma cell line:Hs 863.T)
- 10706-109H4 (pleomorphic hepatocellular carcinoma cell line:SNU-387)
- 10707-109H5 (transitional cell carcinoma cell line:Hs 769.T)
- 10708-109H6 (alveolar cell carcinoma cell line:SW 1573)
- 10709-109H7 (bronchioalveolar carcinoma cell line:NCI-H358)
- 10710-109H8 (bronchogenic carcinoma cell line:ChaGo-K-1)
- 10711-109H9 (fibrous histiocytoma cell line:GCT TIB-223)
- 10712-109I1 (hairy cell leukemia cell line:Mo)
- 10713-109I2
- 10714-109I3
- 10715-109I4 (bronchioalveolar carcinoma cell line:NCI-H650)
- 10716-109I5
- 10717-109I6 (acantholytic squamous carcinoma cell line:HCC1806)
- 10718-109I7 (biphenotypic B myelomonocytic leukemia cell line:MV-4-11)
- 10719-109I8 (carcinoid cell line:SK-PN-DW)
- 10720-109I9
- 10721-110A1 (leiomyoblastoma cell line:G-402)
- 10722-110A2 (leiomyosarcoma cell line:Hs 5.T)
- 10723-110A3 (pharyngeal carcinoma cell line:Detroit 562)
- 10724-110A4
- 10725-110A5
- 10726-110A6 (liposarcoma cell line:SW 872)
- 10727-110A7 (lymphangiectasia cell line:DS-1)
- 10728-110A8 (neuroepithelioma cell line:SK-N-MC)
- 10729-110A9 (neurofibroma cell line:Hs 53.T)
- 10730-110B1 (non-small cell lung cancer cell line:NCI-H1385)
- 10731-110B2
- 10732-110B3 (pagetoid sarcoma cell line:Hs 925.T)
- 10733-110B4
- 10734-110B5
- 10735-110B6 (carcinoid cell line:NCI-H727)
- 10736-110B7
- 10737-110B8 (spindle cell sarcoma cell line:Hs 132.T)
- 10738-110B9
- 10739-110C1
- 10740-110C2
- 10741-110C3
- 10742-110C4 (lung adenocarcinoma, papillary cell line:NCI-H441)
- 10743-110C5
- 10744-110C6 (mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162)
- 10745-110C7
- 10746-110C8
- 10747-110C9
- 10748-110D1
- 10749-110D2
- 10750-110D3
- 10751-110D4
- 10752-110D5 (leukemia, chronic megakaryoblastic cell line:MEG-01)
- 10753-110D6
- 10754-110D7
- 10755-110D8
- 10756-110D9
- 10757-110E1
- 10758-110E2 (fibrosarcoma cell line:HT-1080)
- 10759-110E3 (medulloblastoma cell line:ONS-76)
- 10760-110E4 (bronchial squamous cell carcinoma cell line:KNS-62)
- 10761-110E5
- 10762-110E6
- 10763-110E7
- 10764-110E8 (acute myeloid leukemia (FAB M5) cell line:NOMO-1)
- 10765-110E9 (acute myeloid leukemia (FAB M2) cell line:NKM-1)
- 10766-110F1 (chronic myelogenous leukemia (CML) cell line:MEG-A2)
- 10767-110F2
- 10768-110F3
- 10769-110F4
- 10770-110F5 (acute myeloid leukemia (FAB M5) cell line:P31/FUJ)
- 10771-110F6
- 10772-110F7 (myelodysplastic syndrome cell line:SKM-1)
- 10773-110F8
- 10774-110F9 (neuroectodermal tumor cell line:TASK1)
- 10775-110G1 (lymphoma, malignant, hairy B-cell cell line:MLMA)
- 10776-110G2 (thyroid carcinoma cell line:KHM-5M)
- 10777-110G3 (NK T cell leukemia cell line:KHYG-1)
- 10778-110G4 (hepatic mesenchymal tumor cell line:LI90)
- 10779-110G5
- 10780-110G6
- 10781-110G7 (somatostatinoma cell line:QGP-1)
- 10782-110G8 (liposarcoma cell line:KMLS-1)
- 10784-110H1 (mucinous cystadenocarcinoma cell line:MCAS)
- 10785-110H2 (choriocarcinoma cell line:SCH)
- 10786-110H3 (testicular germ cell embryonal carcinoma cell line:ITO-II)
- 10787-110H4 (rhabdomyosarcoma cell line:KYM-1)
- 10788-110H5 (acute myeloid leukemia (FAB M2) cell line:Kasumi-1)
- 10789-110H6 (acute myeloid leukemia (FAB M0) cell line:Kasumi-3)
- 10790-110H7 (teratocarcinoma cell line:NCC-IT-A3)
- 10791-110H8 (keratoacanthoma cell line:HKA-1)
- 10792-110H9 (acute myeloid leukemia (FAB M2) cell line:Kasumi-6)
- 10793-110I1
- 10794-110I2
- 10795-110I3 (anaplastic large cell lymphoma cell line:Ki-JK)
- 10796-110I4 (adenocarcinoma cell line:IM95m)
- 10797-110I5 (tubular adenocarcinoma cell line:SUIT-2)
- 10798-110I6 (teratocarcinoma cell line:NCR-G1)
- 10799-110I7
- 10800-110I8 (small cell cervical cancer cell line:HCSC-1)
- 10801-110I9 (chronic myeloblastic leukemia (CML) cell line:KCL-22)
- 10802-111A1 (acute myeloid leukemia (FAB M7) cell line:MKPL-1)
- 10803-111A2 (thymic carcinoma cell line:Ty-82)
- 10804-111A3
- 10805-111A4 (anaplastic squamous cell carcinoma cell line:RPMI 2650)
- 10806-111A5
- 10807-111A6 (teratocarcinoma cell line:PA-1)
- 10808-111A7 (hereditary spherocytic anemia cell line:WIL2-NS)
- 10809-111A8 (Wilms' tumor cell line:G-401)
- 10810-111A9 (adrenal cortex adenocarcinoma cell line:SW-13)
- 10811-111B1
- 10814-111B4
- 10815-111B5 (epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1)
- 10816-111B6 (epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2)
- 10817-111B7 (epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3)
- 10818-111B8 (hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1)
- 10819-111B9 (hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2)
- 10820-111C1 (hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3)
- 10824-111C5 (chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1)
- 10825-111C6 (chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2)
- 10826-111C7 (chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3)
- 10827-111C8 (acute myeloid leukemia (FAB M0) cell line:KG-1)
- 10828-111C9 (acute myeloid leukemia (FAB M1) cell line:HYT-1)
- 10829-111D1 (acute myeloid leukemia (FAB M3) cell line:HL60)
- 10830-111D2 (acute myeloid leukemia (FAB M4) cell line:FKH-1)
- 10831-111D3 (acute myeloid leukemia (FAB M4) cell line:HNT-34)
- 10832-111D4 (acute myeloid leukemia (FAB M4eo) cell line:EoL-1)
- 10833-111D5 (acute myeloid leukemia (FAB M4eo) cell line:EoL-3)
- 10834-111D6 (acute myeloid leukemia (FAB M5) cell line:U-937 DE-4)
- 10835-111D7 (acute myeloid leukemia (FAB M6) cell line:EEB)
- 10836-111D8 (acute myeloid leukemia (FAB M6) cell line:F-36E)
- 10837-111D9 (acute myeloid leukemia (FAB M6) cell line:F-36P)
- 10838-111E1 (medulloblastoma cell line:D283 Med)
- 10839-111E2 (large cell lung carcinoma cell line:NCI-H460)
- 10841-111E4 (small cell lung carcinoma cell line:DMS 144)
- 10842-111E5 (small cell lung carcinoma cell line:NCI-H82)
- 10843-111E6 (merkel cell carcinoma cell line:MKL-1)
- 10844-111E7 (merkel cell carcinoma cell line:MS-1)
- 10845-111E8 (mesothelioma cell line:NCI-H28)
- 10846-111E9 (mesothelioma cell line:NCI-H226)
- 10847-111F1 (mesothelioma cell line:NCI-H2052)
- 10848-111F2 (mesothelioma cell line:NCI-H2452)
- 10849-111F3 (mesothelioma cell line:Mero-14)
- 10850-111F4 (mesothelioma cell line:Mero-25)
- 10851-111F5 (mesothelioma cell line:Mero-41)
- 10852-111F6 (mesothelioma cell line:Mero-48a)
- 10853-111F7 (mesothelioma cell line:Mero-82)
- 10854-111F8 (mesothelioma cell line:Mero-83)
- 10855-111F9 (mesothelioma cell line:Mero-84)
- 10856-111G1 (mesothelioma cell line:Mero-95)
- 10857-111G2 (mesothelioma cell line:No36)
- 10858-111G3 (mesothelioma cell line:ONE58)
- 11556-120C8 (Fibroblast - skin dystrophia myotonica, donor1)
- 11557-120C9 (Fibroblast - skin dystrophia myotonica, donor2)
- 11560-120D3 (Fibroblast - skin dystrophia myotonica, donor3)
- 11756-123H1 (mesenchymal precursor cell - ovarian cancer left ovary, donor1)
- 11757-123H2 (mesenchymal precursor cell - ovarian cancer right ovary, donor1)
- 11758-123H3 (mesenchymal precursor cell - ovarian cancer metastasis, donor1)
- 11759-123H4 (mesenchymal precursor cell - ovarian cancer right ovary, donor2)
- 11760-123H5 (mesenchymal precursor cell - ovarian cancer left ovary, donor3)
- 11761-123H6 (mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02))
- 11762-123H7 (mesenchymal precursor cell - ovarian cancer metastasis, donor3)
- 11774-124A1 (CD41+ megakaryocyte cancer, donor1)
- 11776-124A3 (CD41+ megakaryocyte cancer, donor2)
- 11778-124A5 (CD41+ megakaryocyte cancer, donor3)
- 11833-124G6 (mesenchymal precursor cell - ovarian cancer left ovary, donor2)
- 11834-124G7
- 11835-124G8 (mesenchymal precursor cell - ovarian cancer metastasis, donor2)
- 11836-124G9 (mesenchymal precursor cell - ovarian cancer left ovary, donor4)
- 11837-124H1 (mesenchymal precursor cell - ovarian cancer right ovary, donor4)
- 11838-124H2 (mesenchymal precursor cell - ovarian cancer metastasis, donor4)
- 11841-124H5 (serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1)
- 11842-124H6 (mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G))
- 11843-124H7 (serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1)
- 11844-124H8
- 11890-125D9 (Hep-2 cells treated with Streptococci strain 5448, biol_rep1)
- 11891-125E1 (Hep-2 cells treated with Streptococci strain 5448, biol_rep2)
- 11892-125E2 (Hep-2 cells treated with Streptococci strain 5448, biol_rep3)
- 11893-125E3
- 11894-125E4 (Hep-2 cells treated with Streptococci strain JRS4, biol_rep1)
- 11895-125E5 (Hep-2 cells treated with Streptococci strain JRS4, biol_rep2)
- 11896-125E6 (Hep-2 cells treated with Streptococci strain JRS4, biol_rep3)
- 11897-125E7
- 11898-125E8 (Hep-2 cells mock treated, biol_rep1)
- 11899-125E9 (Hep-2 cells mock treated, biol_rep2)
- 11900-125F1 (Hep-2 cells mock treated, biol_rep3)
- 11921-125H4 (Fibroblast - Gingival, donor6 (aggressive periodontitis))
- 11923-125H6 (Fibroblast - Gingival, donor7 (aggressive periodontitis))
- 11925-125H8 (Fibroblast - Gingival, donor8 (chronic periodontitis))
- 11928-125I2 (Fibroblast - Gingival, donor10 (periodontitis))
- 12159-128G8 (MC1+Gr1+ myeloid-derived suppressor cells cancer, donor1 (10,11,12 3LL))
- 12161-128H1 (MC1+Gr1+ myeloid-derived suppressor cells cancer, donor2 (0127 3LL))
- 12163-128H3 (MC1+Gr1+ myeloid-derived suppressor cells cancer, donor3 (0128 3LL))
- 13031-139E7 (MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1)
- 13032-139E8 (MCF7 breast cancer cell line response to EGF1)
- 13033-139E9 (MCF7 breast cancer cell line response to EGF1)
- 13034-139F1 (MCF7 breast cancer cell line response to EGF1)
- 13035-139F2 (MCF7 breast cancer cell line response to EGF1)
- 13036-139F3 (MCF7 breast cancer cell line response to EGF1)
- 13037-139F4 (MCF7 breast cancer cell line response to EGF1)
- 13038-139F5 (MCF7 breast cancer cell line response to EGF1)
- 13039-139F6 (MCF7 breast cancer cell line response to EGF1)
- 13040-139F7 (MCF7 breast cancer cell line response to EGF1)
- 13041-139F8 (MCF7 breast cancer cell line response to EGF1)
- 13042-139F9 (MCF7 breast cancer cell line response to EGF1)
- 13043-139G1 (MCF7 breast cancer cell line response to EGF1)
- 13044-139G2 (MCF7 breast cancer cell line response to EGF1)
- 13045-139G3 (MCF7 breast cancer cell line response to EGF1)
- 13046-139G4 (MCF7 breast cancer cell line response to EGF1)
- 13048-139G6 (MCF7 breast cancer cell line response to HRG)
- 13049-139G7 (MCF7 breast cancer cell line response to HRG)
- 13050-139G8 (MCF7 breast cancer cell line response to HRG)
- 13051-139G9 (MCF7 breast cancer cell line response to HRG)
- 13052-139H1 (MCF7 breast cancer cell line response to HRG)
- 13053-139H2 (MCF7 breast cancer cell line response to HRG)
- 13054-139H3 (MCF7 breast cancer cell line response to HRG)
- 13055-139H4 (MCF7 breast cancer cell line response to HRG)
- 13056-139H5 (MCF7 breast cancer cell line response to HRG)
- 13057-139H6 (MCF7 breast cancer cell line response to HRG)
- 13058-139H7 (MCF7 breast cancer cell line response to HRG)
- 13059-139H8 (MCF7 breast cancer cell line response to HRG)
- 13060-139H9 (MCF7 breast cancer cell line response to HRG)
- 13061-139I1 (MCF7 breast cancer cell line response to HRG)
- 13062-139I2 (MCF7 breast cancer cell line response to HRG)
- 13063-139I3 (J2E erythroblastic leukemia response to erythropoietin)
- 13064-139I4 (J2E erythroblastic leukemia response to erythropoietin)
- 13065-139I5 (J2E erythroblastic leukemia response to erythropoietin)
- 13066-139I6 (J2E erythroblastic leukemia response to erythropoietin)
- 13067-139I7 (J2E erythroblastic leukemia response to erythropoietin)
- 13068-139I8 (J2E erythroblastic leukemia response to erythropoietin)
- 13069-139I9 (J2E erythroblastic leukemia response to erythropoietin)
- 13070-140A1 (J2E erythroblastic leukemia response to erythropoietin)
- 13071-140A2 (J2E erythroblastic leukemia response to erythropoietin)
- 13072-140A3 (J2E erythroblastic leukemia response to erythropoietin)
- 13073-140A4 (J2E erythroblastic leukemia response to erythropoietin)
- 13074-140A5 (J2E erythroblastic leukemia response to erythropoietin)
- 13075-140A6 (J2E erythroblastic leukemia response to erythropoietin)
- 13076-140A7 (J2E erythroblastic leukemia response to erythropoietin)
- 13077-140A8 (J2E erythroblastic leukemia response to erythropoietin)
- 13078-140A9 (J2E erythroblastic leukemia response to erythropoietin)